Cardiac resynchronisation therapy benefits women more than men
15th February 2011
By Staff writer
WOMEN appear to benefit from cardiac resynchronisation therapy for heart failure more than men, it’s been shown for the first time.
A study analysed 1820 patients allocated to cardiac resynchronisation therapy with defibrillator (CRT-D) or implantable cardioverter-defibrillator. While males received significant benefit from CRT-D, females had a 69% reduction in death or heart failure and 72% reduction in all-cause mortality.
“These more favourable results for women were associated with consistently greater echocardiographic evidence of reverse cardiac remodelling in women than men,” researchers said.
J Am Coll Cardiol 2011;57:813-20
